EGFR and non-small cell lung carcinoma: Based on the work of Chen et al. and Garcia-Diaz et al.,10,14 it is plausible that IFN-γ may activate STAT3 and drive PD-L1 expression in EGFR-mutated NSCLC, although this mechanism has yet to be elucidated in clinical specimens.